WCG and InformedDNA will launch new genetics and precision medicine center

| By | Clinical Trials, Precision Medicine
0
167

WCG (WIRB-Copernicus Group) Clinical Services Division, the leading provider of solutions that measurably improve the quality and efficiency of clinical research, has entered a strategic partnership with InformedDNA, the largest independent provider of genetics expert services.

Through this partnership, the companies will create the “Center for Genetics and Precision Medicine in Clinical Trials” to support biopharmaceutical companies, contract research organizations (CROs), institutions and investigator sites in the design and conduct of clinical trials that use genetics.

Under the strategic partnership, WCG and InformedDNA will launch the Center for Genetics and Precision Medicine in Clinical Trials, which will unite InformedDNA’s substantial genetics resources and expertise with WCG’s global network of 550 experts in clinical trial optimization and its proprietary industry Knowledge Base™. WCG combines its deep understanding of 95% of all industry-sponsored protocols with InformedDNA’s industry-leading team of 50 nationally-distributed genetics specialists and its extensive genetic database across all therapeutic categories. Together, the partners will deliver unparalleled insights and guidance regarding the optimal application of genetics in clinical trials. Specifically, they will tackle the challenges and opportunities of applying genetic information in trial and protocol design as well as harness the power of genetics to identify, recruit, and manage patients in clinical trials.

The companies will offer a genetics and clinical development solution to optimize the design of protocols and to ensure that all genetic information is appropriately applied to study design. The solution will enable sponsors to identify hard-to-find patient populations, reduce their exposure to risk, identify broader potential therapeutic indications, and increase the overall value of each trial subject.

WCG (Princetown, New Jersey, USA) provides regulatory and ethical review services for human research. The company reviews various new protocols. It also provides clinical and human gene therapy research services and laboratory biosafety consulting services; solutions for human research protections and clinical research support.

InformedDNA (St. Petersburg, Florida, USA) is the authority on the appropriate use of genetic testing – leveraging the expertiseof independent board-certified genetics specialists to help ensure health plans, hospitals, employers, community clinicians and patients all have access to the highest quality genetic services. In addition to supporting clinical trials, InformedDNA’s key offerings include clinical genetic counseling, genetic testing utilization management, and personalized hereditary risk assessment and prevention solutions.

SOURCE: wcg
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.